Willingness to Receive a COVID-19 Vaccination Among Incarcerated or Detained Persons in Correctional and Detention Facilities — Four States, September–December 2020

Stern, M.; Piasecki, Alexandra M; Strick, Lara; Rajeshwar, Poornima; Tyagi, Erika; Dolovich, Sharon; Patel, Priti R.; Fukunaga, Rena; Furukawa, Nathan W.

doi:10.15585/mmwr.mm7013a3

Cited by 70 publications

(100 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The COVID-19 vaccination acceptance rate among people incarcerated in BOP institutions is similar to the rate reported by the California state prison system (66.5%), and higher than an estimate of vaccination intent measured among people incarcerated across 16 prisons and jails in four states (45%) during a similar time period. [10] , [11] In addition, factors associated with vaccination acceptance in BOP are consistent with factors identified in these two studies; specifically, vaccination intent and acceptance in these correctional populations are consistently lower among non-Hispanic Black participants, younger adults, and women and higher among non-Hispanic White participants. [10] , [11] Similar demographic trends have emerged from general population surveys of vaccination intent as well.…”

Section: Discussionsupporting

confidence: 58%

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021

Hagan

Dusseau

Crockett

et al. 2021

Vaccine

View full text Add to dashboard Cite

Objectives To describe COVID-19 vaccine distribution operations in United States Federal Bureau of Prisons (BOP) institutions and offices from December 16, 2020—April 14, 2021, report vaccination coverage among staff and incarcerated people, and identify factors associated with vaccination acceptance among incarcerated people. Methods The BOP COVID-19 vaccination plan and implementation timeline are described. Descriptive statistics and vaccination coverage were calculated for the BOP incarcerated population using data from the BOP electronic medical record. Coverage among staff was calculated using data from the Centers for Disease Control and Prevention Vaccination Administration Management System. Vaccination coverage in the BOP versus the overall United States adult population was compared by state/territory. Univariate and multivariable logistic regression models were developed to identify demographic, health-related, and institution-level factors associated with vaccination acceptance among incarcerated people, using hierarchical linear modeling to account for institution-level clustering. Results By April 14, 2021, BOP had offered COVID-19 vaccination to 37,870 (100%) staff and 88,173/126,413 (69.8%) incarcerated people, with acceptance rates of 50.2% and 64.2%, respectively. At the time of analysis, vaccination coverage in BOP was comparable to coverage in the overall adult population in the states and territories where BOP institutions and offices are located. Among incarcerated people, factors associated with lower vaccination acceptance included younger age, female sex, non-Hispanic Black and Asian race/ethnicity, and having few underlying medical conditions; factors associated with higher acceptance included having a prior SARS-CoV-2 infection, being born outside the United States, and being assigned to a Federal Detention Center. Conclusions Early COVID-19 vaccination efforts in BOP have achieved levels of coverage similar to the general population. To build on this initial success, BOP can consider strategies including re-offering vaccination to people who initially refused and tailoring communication strategies to groups with lower acceptance rates.

show abstract

Section: Discussionsupporting

confidence: 58%

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021

Hagan

Dusseau

Crockett

et al. 2021

Vaccine

View full text Add to dashboard Cite

show abstract

“…The result of this study was in line with a study done in four states in the United States of America 44.9%. 27 The acceptability of the COVID-19 vaccine was higher in this study than in other countries, with 36.8% in Jordan, 28 37.2% in Hong Kong, 29 and 34.9% among Jordanian university students. 30 The probable reason for the discrepancy between the current result and other studies may be due to socio-demographic, socio-economic, or time differences.…”

Section: Discussioncontrasting

confidence: 52%

COVID-19 Vaccination Acceptance and Its Associated Factors in Sodo Town, Wolaita Zone, Southern Ethiopia: Cross-Sectional Study

Mesele¹

2021

IDR

View full text Add to dashboard Cite

Background Coronavirus disease (COVID-19) pandemic has still affected many countries around the world. The COVID-19 vaccine has been presented as the perfect solution for solving the current pandemic. Understanding the willingness of the community to receive the COVID-19 vaccine will help in the development and implementation of effective COVID-19 vaccination promotion programs. The aim of this study was to assess the COVID-19 vaccination acceptance and its associated factors in Sodo town, Wolaita zone, Southern Ethiopia. Methods A community-based cross-sectional study was conducted among 415 participants in Wolaita Sodo, from April 1 to 30, 2021. To collect data, structured interviewer administered questionnaire was used. A p-value ≤0.05 in a multivariable logistic regression model was considered statistically significant. Results Of 415 participants, 189 (45.5%) of them accepted of COVID-19 vaccines if available. Sex (AOR=2.15, 95% CI: 1.29, 3.56), educational status (AOR=3.09, 95% CI: 1.50, 6.37), mass media (AOR=1.97, 95% CI: 1.06, 3.63), received any vaccination during childhood (AOR=5.16, 95% CI: 2.44, 10.92), family members have been diagnosed with COVID-19 (AOR=4.40, 95% CI: 2.1, 9.25), friends have been diagnosed with COVID-19 (AOR=3.91, 95% CI: 1.52, 10.04), and respondents have tested for COVID-19 (AOR=4.40, 95% CI: 1.70, 11.36) were significantly associated with acceptance of COVID-19 vaccine. Conclusion The prevalence of COVID-19 vaccination acceptance was law. To enhance the acceptance of COVID-19 vaccine, the government with different stakeholders should strengthen public education using mass media about the advantage of getting COVID-19 vaccination.

show abstract

“…This is especially pertinent given the disregard for incarcerated people’s rights and health which has, in turn, reduced trust in medical services. A recent survey of people in correctional and detention facilities found that 55% would hesitate or refuse to receive a COVID-19 vaccine, among whom 20% would not get a vaccine due to lack of trust for health care, correctional, or government personnel or institutions [ 49 ]. Thus, future work must address hesitancy barriers to vaccine uptake, including longstanding neglect and deliberate indifference to serious health needs and the ignoring of risks of harm by correctional health care systems [ 50 – 52 ].…”

Section: Discussionmentioning

confidence: 99%

COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans

Strodel¹,

Dayton

Garrison-Desany

et al. 2021

PLoS ONE

View full text Add to dashboard Cite

Background Carceral facilities are epicenters of the COVID-19 pandemic, placing incarcerated people at an elevated risk of COVID-19 infection. Due to the initial limited availability of COVID-19 vaccines in the United States, all states have developed allocation plans that outline a phased distribution. This study uses document analysis to compare the relative prioritization of incarcerated people, correctional staff, and other groups at increased risk of COVID-19 infection and morbidity. Methods and findings We conducted a document analysis of the vaccine dissemination plans of all 50 US states and the District of Columbia using a triple-coding method. Documents included state COVID-19 vaccination plans and supplemental materials on vaccine prioritization from state health department websites as of December 31, 2020. We found that 22% of states prioritized incarcerated people in Phase 1, 29% of states in Phase 2, and 2% in Phase 3, while 47% of states did not explicitly specify in which phase people who are incarcerated will be eligible for vaccination. Incarcerated people were consistently not prioritized in Phase 1, while other vulnerable groups who shared similar environmental risk received this early prioritization. States’ plans prioritized in Phase 1: prison and jail workers (49%), law enforcement (63%), seniors (65+ years, 59%), and long-term care facility residents (100%). Conclusions This study demonstrates that states’ COVID-19 vaccine allocation plans do not prioritize incarcerated people and provide little to no guidance on vaccination protocols if they fall under other high-risk categories that receive earlier priority. Deprioritizing incarcerated people for vaccination misses a crucial opportunity for COVID-19 mitigation. It also raises ethical and equity concerns. As states move forward with their vaccine distribution, further work must be done to prioritize ethical allocation and distribution of COVID-19 vaccines to incarcerated people.

show abstract

Willingness to Receive a COVID-19 Vaccination Among Incarcerated or Detained Persons in Correctional and Detention Facilities — Four States, September–December 2020

Cited by 70 publications

References 8 publications

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021

COVID-19 Vaccination Acceptance and Its Associated Factors in Sodo Town, Wolaita Zone, Southern Ethiopia: Cross-Sectional Study

COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans

Contact Info

Product

Resources

About